TABLE 1.
Baseline characteristics (ITT) | |||
---|---|---|---|
EPO (n = 45) | Placebo (n = 39) | Total (n = 84) | |
Age—years (SD) | 48.5 ± 16.2 | 46.6 ± 15.0 | |
Age ≥60 years—no. (%) | 8 (18%) | 10 (26%) | 18 (21%) |
Female—no. (%) | 12 (27%) | 6 (15%) | 18 (21%) |
ABSI Score ≥7—no. (%) | 24 (53%) | 26 (67%) | 34 (40%) |
TBS-Sum—% (SD) | 24.9 ± 11.7 | 26.6 ± 13.3 | |
Death—no. (%) | 1 (2%) | 1 (2%) | 2 (2%) |
Subgroups—no. (%) | |||
Insulin | 17 (38%) | 19 (49%) | 36 (43%) |
NASIDs (>1) | 30 (67%) | 11 (28%) | 41 (49%) |
Vasopressors | 20 (44%) | 23 (59%) | 43 (51%) |
Descriptive statistics are mean and standard deviation or absolute and relative (%) frequency for the ITT population. ABSI score, Abbreviated burn severity index score; The ABSI Score describes the severity of the burn or scald injury and the patient’s prognosis. The lower the ABSI score, the better the patient’s prognosis. An ABSI of over seven relates to a severe threat to life, with a likelihood of survival ranging between 70% and 0% [46]., 1982. TBS-Sum, total body surface thermally injured in %.